H. Lundbeck A/S
H. Lundbeck A/S
Explore linked clinical trials.16 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Extension Trial of Asedebart in Participants With Congenital Adrenal Hyperplasia | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, steroid inherited metabolic disorder | Not yet recruiting | Phase 2 | 2026-10-05 | NCT07859293 | |
| Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context | Disease Attributes, Emergencies, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Enrolling by invitation | Phase 3 | 2026-09-30 | NCT06428838 | |
| A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Active, not recruiting | Phase 1 | 2026-09-09 | NCT06557850 | |
| A Study of Eptinezumab in Pediatric Participants With Episodic Migraine | Episodic Migraine | Recruiting | Phase 3 | 2026-09-09 | NCT05897320 | |
| A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 | 2026-09-08 | NCT07514858 | |
| A Trial of Lu AG13909 in Adult Participants With Cushing's Disease | ACTH-dependent Cushing syndrome, brain disorder, central nervous system disorder, endocrine system disorder, hyperpituitarism, hypothalamic disorder, nervous system disorder, pituitary gland disorder | Recruiting | Phase 2 | 2026-08-21 | NCT06471829 | |
| A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine | Chronic Migraine in Children | Recruiting | Phase 3 | 2026-08-21 | NCT04965675 | |
| A Trial of Lu AH69593 in Healthy Participants | Healthy Participants | Not yet recruiting | Phase 1 | 2026-08-20 | NCT07775261 | |
| A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy | Disorders of Excessive Somnolence, Dyssomnias, Sleep Disorders, Intrinsic, narcolepsy, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Phase 1 | 2026-08-12 | NCT07613710 | |
| A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD) | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 1 | 2026-08-10 | NCT07513441 | |
| A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) | autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, synucleinopathy | Active, not recruiting | Phase 3 | 2026-07-14 | NCT06706622 | |
| Eptinezumab for Chronic Headache in Idiopathic Intracranial Hypertension | brain disorder, central nervous system disorder, intracranial hypertension, nervous system disorder, pseudotumor cerebri | Not yet recruiting | Phase 3 | 2026-06-12 | NCT07645833 | |
| A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Phase 3 | 2026-06-12 | NCT05164172 | |
| A Study of Lu AF82422 in Participants With Multiple System Atrophy | autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, pure autonomic failure, synucleinopathy | Active, not recruiting | Phase 2 | 2026-04-13 | NCT05104476 | |
| A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, steroid inherited metabolic disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-09 | NCT05669950 | |
| Observational Study in Multiple System Atrophy | autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, synucleinopathy | Active, not recruiting | Not stated | 2025-12-08 | NCT05453058 |